Siren, L.l.c.

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR/A2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-23
Total Holdings
117
Total Value
1772780355
Accession Number
0002005245-25-000008
Form Type
13F-HR/A
Manager Name
Siren
Data Enrichment
96% identified
112 identified5 unidentified

Holdings

117 positions
Manager:
Search and click to pin securities to the top
Page 1 of 6
Scholar Rock Holding Corp
Shares:9.3M
Value:$297.4M
07725L102
Shares:498.7K
Value:$135.7M
Kymera Therapeutics, Inc.
Shares:3.2M
Value:$88.7M
Blueprint Medicines Corp
Shares:726.2K
Value:$64.3M
Crinetics Pharmaceuticals, Inc.
Shares:1.7M
Value:$56.6M
Apellis Pharmaceuticals, Inc.
Shares:2.6M
Value:$56.4M
Disc Medicine, Inc.
Shares:1.1M
Value:$53.2M
SOLENO THERAPEUTICS INC
Shares:727.3K
Value:$52.0M
Ascendis Pharma A/S
Shares:287.4K
Value:$44.8M
Merus N.V.
Shares:1.0M
Value:$43.9M
Bicara Therapeutics Inc.
Shares:3.3M
Value:$42.6M
Centessa Pharmaceuticals plc
Shares:3.0M
Value:$42.6M
NewAmsterdam Pharma Co N.V.
Shares:1.9M
Value:$39.1M
Edgewise Therapeutics, Inc.
Shares:1.7M
Value:$37.3M
ARROWHEAD PHARMACEUTICALS, INC.
Shares:2.7M
Value:$34.0M
Avidity Biosciences, Inc.
Shares:1.1M
Value:$32.8M
Wave Life Sciences Ltd.
Shares:3.7M
Value:$29.9M
Taboola.com Ltd.
Shares:10.0M
Value:$29.4M
Dyne Therapeutics, Inc.
Shares:2.7M
Value:$28.4M
Solid Biosciences Inc.
Shares:7.4M
Value:$27.4M